Science
Learn about the science behind our innovative regenerative medicine and immunotherapy platforms here at Creative Medical Technology Holdings, Inc.
.png)
Enhanced Allogenic Platform
Composition
Composed of Perinatal Derived Tissue Cells
Immediately available allogenic cell line
Properties
The immunomodulatory properties help to treat immune, endocrine, and multiple other based disorders
Supercharged Autologous
Immunotherapy Platform
Collection
White blood cells (including Treg cells) will be collected from the patient and undergo centrifugation.
Supercharge
The patient’s own white blood cells are then supercharged in the lab with stimulated donor cells.
Expansion
The patient’s cultured cells continue to further expand.
Infusion
The patient’s supercharged cells are infused back into the body.
Reprogrammed Cell Therapy Platform
Reprogramming
Take adult cells (skin or blood) and mix with reprogramming factors to create iPSCs.
Differentiating
The iPSCs are further differentiated into any human cell type.
Rapid Autologous Therapies
Harvest Patient's Bone Marrow
Harvested stem cell product contains endothelial progenitor cells, hematopoietic and mesenchymal cells with dilution or contamination of blood.
.png)
Autologous Stem Cell Injection
No rejection or immunosuppression required as the cells are autologous. Cells help to stimulate natural healing, improve muscle tissue, and promote increased blood flow.
.png)
Connect With Us
Interested in learning more?
Connect with us now by filling out our form on the contact page.
